232 related articles for article (PubMed ID: 38134886)
21. Increasing the Targeting Scope of CRISPR Base Editing System Beyond NGG.
Yu SY; Birkenshaw A; Thomson T; Carlaw T; Zhang LH; Ross CJD
CRISPR J; 2022 Apr; 5(2):187-202. PubMed ID: 35238621
[TBL] [Abstract][Full Text] [Related]
22. Functional interrogation of DNA damage response variants with base editing screens.
Cuella-Martin R; Hayward SB; Fan X; Chen X; Huang JW; Taglialatela A; Leuzzi G; Zhao J; Rabadan R; Lu C; Shen Y; Ciccia A
Cell; 2021 Feb; 184(4):1081-1097.e19. PubMed ID: 33606978
[TBL] [Abstract][Full Text] [Related]
23. Emerging applications of genome-editing technology to examine functionality of GWAS-associated variants for complex traits.
Smith AJP; Deloukas P; Munroe PB
Physiol Genomics; 2018 Jul; 50(7):510-522. PubMed ID: 29652634
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of prime editing outcomes in human embryonic stem cells.
Habib O; Habib G; Hwang GH; Bae S
Nucleic Acids Res; 2022 Jan; 50(2):1187-1197. PubMed ID: 35018468
[TBL] [Abstract][Full Text] [Related]
25. CRISPR-Cas9 DNA Base-Editing and Prime-Editing.
Kantor A; McClements ME; MacLaren RE
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872311
[TBL] [Abstract][Full Text] [Related]
26. Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation.
Rao S; Yao Y; Bauer DE
Genome Med; 2021 Mar; 13(1):41. PubMed ID: 33691767
[TBL] [Abstract][Full Text] [Related]
27. Perturbing proteomes at single residue resolution using base editing.
Després PC; Dubé AK; Seki M; Yachie N; Landry CR
Nat Commun; 2020 Apr; 11(1):1871. PubMed ID: 32313011
[TBL] [Abstract][Full Text] [Related]
28. High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.
Montalbano A; Canver MC; Sanjana NE
Mol Cell; 2017 Oct; 68(1):44-59. PubMed ID: 28985510
[TBL] [Abstract][Full Text] [Related]
29. Prediction of efficiencies for diverse prime editing systems in multiple cell types.
Yu G; Kim HK; Park J; Kwak H; Cheong Y; Kim D; Kim J; Kim J; Kim HH
Cell; 2023 May; 186(10):2256-2272.e23. PubMed ID: 37119812
[TBL] [Abstract][Full Text] [Related]
30. Generation of a more efficient prime editor 2 by addition of the Rad51 DNA-binding domain.
Song M; Lim JM; Min S; Oh JS; Kim DY; Woo JS; Nishimasu H; Cho SR; Yoon S; Kim HH
Nat Commun; 2021 Sep; 12(1):5617. PubMed ID: 34556671
[TBL] [Abstract][Full Text] [Related]
31. Improvement of base editors and prime editors advances precision genome engineering in plants.
Hua K; Han P; Zhu JK
Plant Physiol; 2022 Mar; 188(4):1795-1810. PubMed ID: 34962995
[TBL] [Abstract][Full Text] [Related]
32. A new era in functional genomics screens.
Przybyla L; Gilbert LA
Nat Rev Genet; 2022 Feb; 23(2):89-103. PubMed ID: 34545248
[TBL] [Abstract][Full Text] [Related]
33. Methods for Scarless, Selection-Free Generation of Human Cells and Allele-Specific Functional Analysis of Disease-Associated SNPs and Variants of Uncertain Significance.
Coggins NB; Stultz J; O'Geen H; Carvajal-Carmona LG; Segal DJ
Sci Rep; 2017 Nov; 7(1):15044. PubMed ID: 29118424
[TBL] [Abstract][Full Text] [Related]
34. Interpreting non-coding disease-associated human variants using single-cell epigenomics.
Gaulton KJ; Preissl S; Ren B
Nat Rev Genet; 2023 Aug; 24(8):516-534. PubMed ID: 37161089
[TBL] [Abstract][Full Text] [Related]
35. Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases.
Testa LC; Musunuru K
BioDrugs; 2023 Jul; 37(4):453-462. PubMed ID: 37314680
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag.
Liang SQ; Liu P; Ponnienselvan K; Suresh S; Chen Z; Kramme C; Chatterjee P; Zhu LJ; Sontheimer EJ; Xue W; Wolfe SA
Nat Methods; 2023 Jun; 20(6):898-907. PubMed ID: 37156841
[TBL] [Abstract][Full Text] [Related]
37. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
Geurts MH; de Poel E; Pleguezuelos-Manzano C; Oka R; Carrillo L; Andersson-Rolf A; Boretto M; Brunsveld JE; van Boxtel R; Beekman JM; Clevers H
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34373320
[TBL] [Abstract][Full Text] [Related]
38. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
[TBL] [Abstract][Full Text] [Related]
39. Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.
Hillary VE; Ceasar SA
Bioessays; 2022 Sep; 44(9):e2200032. PubMed ID: 35750651
[TBL] [Abstract][Full Text] [Related]
40. High-Throughput Gene Mutagenesis Screening Using Base Editing.
Després PC; Dubé AK; Yachie N; Landry CR
Methods Mol Biol; 2022; 2477():331-348. PubMed ID: 35524126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
